Special Issue "Exploiting Marine 'Omics' Technologies for the Biodiscovery of Marine Natural Products with Activity against Fish Diseases"
A special issue of Marine Drugs (ISSN 1660-3397). This special issue belongs to the section "Marine Biotechnology Related to Drug Discovery or Production".
Deadline for manuscript submissions: 31 December 2023 | Viewed by 133
2. Environmental Research Institute, University College Cork, Cork, Ireland
Interests: microbial ecology; marine biotechnology; metagenomics
Special Issues, Collections and Topics in MDPI journals
The marine environment is host to taxonomically diverse planktonic microorganisms and microbes closely associated in amensal or commensal relationships with higher organisms such as plants and animals. Certain bacterial taxa are antagonistic to fish health, causing diseases such as hemorrhagic septicemia, furunculosis, and vibriosis. Incidences and the prevalence of fish diseases have significant impacts on sustainable food production. New antimicrobial agents are needed to suppress bacterial fish diseases, to reduce the economic impacts of fish diseases, and to combat the spread of antimicrobial resistance in fish pathogens globally. This Special Issue plans to highlight multi-'omics' strategies being employed to discover novel marine natural products with the potential to tackle fish pathogen virulence, to identify new probiotic marine microbial species or consortia with bioprotective effects for the host, and to reduce the prophylactic over-use of antibiotics in marine ecosystems.
Potential topics include, but are not limited to:
- Genomics of marine microbes with a focus on bioactive secondary metabolites;
- Metagenomics of marine microbial consortia;
- Metabolomics of bioactive marine microbes;
- Multi-omics approaches to realize the potential of cryptic secondary metabolism biosynthetic gene clusters;
- Probiotics as bioprotective agents in marine ecosystems;
- The antibiotic resistome of fish pathogens.
Dr. Stephen A. Jackson
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- secondary metabolism biosynthetic gene clusters
- antimicrobial resistance
- fish pathogens